News & Alerts
-
Sep- 2023 -4 September
Healthcare Giants in the Spotlight: UnitedHealthcare vs. Prisma Health
The dispute between UnitedHealthcare and Prisma Health revolves around allegations of breach of contract and the disclosure of confidential information.…
Read More » -
2 September
Japanese Regulators Accept GSK’s Nucala Application For CRSwNP
GlaxoSmithKline (GSK) announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has accepted a supplementary new drug…
Read More » -
2 September
GSK Expands Vaccine Manufacturing With $273 Million Investment in Belgium
GlaxoSmithKline (GSK) is expanding its manufacturing operations in Belgium with a significant investment of over 250 million euros ($273 million).…
Read More » -
2 September
Counterfeit Pills Fueling Overdose Deaths in the U.S. – CDC Report
The United States is facing a concerning and escalating public health crisis as a growing number of overdose deaths are…
Read More » -
1 September
Otsuka Ventures into Psychedelic Medicines with Mindset Pharma Acquisition
Japanese pharmaceutical giant Otsuka is making a significant move into the emerging field of psychedelic medicines by acquiring Canada’s Mindset…
Read More » -
1 September
Sage Therapeutics Announces Major Restructuring Following Zurzuvae FDA Approval
Sage Therapeutics, in response to the FDA’s narrower-than-expected approval of its flagship antidepressant Zurzuvae, has announced significant changes to its…
Read More » -
1 September
Primate Antibody Treatment Prevents Organ Rejection After Transplant – Study
A recent study conducted in non-human primates has unveiled promising potential in using a manmade monoclonal antibody to address the…
Read More » -
1 September
Taking Statins Post-“Bleeding” Stroke May Help Prevent Subsequent Strokes – Study
Using statin medication to lower cholesterol levels following a hemorrhagic stroke may reduce the likelihood of experiencing a subsequent stroke…
Read More » -
1 September
World’s First Subcutaneous Cancer Injection Launched by NHS England
In a groundbreaking development, NHS England has unveiled a revolutionary approach to cancer treatment, offering hope to hundreds of cancer…
Read More » -
Aug- 2023 -31 August
Teva Secures Early Launch of Generic Vivitrol After Settling Patent Case with Alkermes
In a significant legal development, Teva Pharmaceuticals has reached a settlement with Alkermes, the manufacturer of Vivitrol, a medication used…
Read More »